Increase of oxidative stress by a novel PINK1 mutation, P209A

Free Radical Biology and Medicine

Volumn 58, Issue , 2013, Pages 160-169

  Chien, Wei Lin ^a   Lee, Tzeng Ruei ^a   Hung, Shih Ya ^a   Kang, Kai Hsiang ^a   Wu, Ruey Meei ^a,b   Lee, Ming Jen ^a,b   Fu, Wen Mei ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Free radicals; HO 1; Oxidative stress; PINK1; SOD

Indexed keywords

CASPASE 3; DOPAMINE; HEME OXYGENASE 1; LACTATE DEHYDROGENASE; PROTEIN KINASE; PTEN INDUCED PROTEIN KINASE 1; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ARTICLE; CELL DEATH; EXPRESSION VECTOR; GENE MUTATION; GENETIC SCREENING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MISSENSE MUTATION; NEUROBLASTOMA CELL; OXIDATIVE STRESS; PARKINSON DISEASE; PLASMID; PRIORITY JOURNAL;

AGE OF ONSET; CELL LINE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEME OXYGENASE-1; HETEROZYGOTE; HUMANS; LEVODOPA; MALE; MUTATION; OXIDATIVE STRESS; PARKINSON DISEASE; PHOSPHORYLATION; PROTEIN KINASES; SUPEROXIDE DISMUTASE;

EID: 84876019524     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2012.12.008     Document Type: Article

References (52)

1. M. Poulopoulos, O.A. Levy, and R.N. Alcalay The neuropathology of genetic Parkinson's disease Mov. Disord 27 2012 831 842
2. E.M. Valente, P.M. Abou-Sleiman, V. Caputo, M.M. Muqit, K. Harvey, S. Gispert, Z. Ali, D. Del Turco, A.R. Bentivoglio, D.G. Healy, A. Albanese, R. Nussbaum, R. Gonzalez-Maldonado, T. Deller, S. Salvi, P. Cortelli, W.P. Gilks, D.S. Latchman, R.J. Harvey, B. Dallapiccola, G. Auburger, and N.W. Wood Hereditary early-onset Parkinson's disease caused by mutations in PINK1 Science 304 2004 1158 1160
3. P.M. Abou-Sleiman, M.M. Muqit, N.Q. McDonald, Y.X. Yang, S. Gandhi, D.G. Healy, K. Harvey, R.J. Harvey, E. Deas, K. Bhatia, N. Quinn, A. Lees, D.S. Latchman, and N.W. Wood A heterozygous effect for PINK1 mutations in Parkinson's disease? Ann. Neurol. 60 2006 414 419
4. D.G. Healy, P.M. Abou-Sleiman, J.M. Gibson, O.A. Ross, S. Jain, S. Gandhi, D. Gosal, M.M. Muqit, N.W. Wood, and T. Lynch PINK1 (PARK6) associated Parkinson disease in Ireland Neurology 63 2004 1486 1488
5. R. Kumazawa, H. Tomiyama, Y. Li, Y. Imamichi, M. Funayama, H. Yoshino, F. Yokochi, T. Fukusako, Y. Takehisa, K. Kashihara, T. Kondo, B. Elibol, S. Bostantjopoulou, T. Toda, H. Takahashi, F. Yoshii, Y. Mizuno, and N. Hattori Mutation analysis of the PINK1 gene in 391 patients with Parkinson disease Arch. Neurol. 65 2008 802 808
6. A. Beilina, M. Van Der Brug, R. Ahmad, S. Kesavapany, D.W. Miller, G.A. Petsko, and M.R. Cookson Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability Proc. Natl. Acad. Sci. USA 102 2005 5703 5708
7. I. Martin, V.L. Dawson, and T.M. Dawson Recent advances in the genetics of Parkinson's disease Annu. Rev. Genomics Hum. Genet 12 2011 301 325
8. R.D. Mills, C.H. Sim, S.S. Mok, T.D. Mulhern, J.G. Culvenor, and H.C. Cheng Biochemical aspects of the neuroprotective mechanism of PTEN-induced kinase-1 (PINK1) J. Neurochem. 105 2008 18 33
9. L. Silvestri, V. Caputo, E. Bellacchio, L. Atorino, B. Dallapiccola, E.M. Valente, and G. Casari Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism Hum. Mol. Genet 14 2005 3477 3492
10. V. Bonifati, C.F. Rohe, G.J. Breedveld, E. Fabrizio, M. De Mari, C. Tassorelli, A. Tavella, R. Marconi, D.J. Nicholl, H.F. Chien, E. Fincati, G. Abbruzzese, P. Marini, A. De Gaetano, M.W. Horstink, J.A. Maat-Kievit, C. Sampaio, A. Antonini, F. Stocchi, P. Montagna, V. Toni, M. Guidi, A. Dalla Libera, M. Tinazzi, F. De Pandis, G. Fabbrini, S. Goldwurm, A. de Klein, E. Barbosa, L. Lopiano, E. Martignoni, P. Lamberti, N. Vanacore, G. Meco, and B.A. Oostra Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes Neurology 65 2005 87 95
11. E.M. Valente, S. Salvi, T. Ialongo, R. Marongiu, A.E. Elia, V. Caputo, L. Romito, A. Albanese, B. Dallapiccola, and A.R. Bentivoglio PINK1 mutations are associated with sporadic early-onset parkinsonism Ann. Neurol. 56 2004 336 341
12. E.K. Tan, F.S. Refai, M. Siddique, K. Yap, P. Ho, S. Fook-Chong, and Y. Zhao Clinically reported heterozygous mutations in the PINK1 kinase domain exert a gene dosage effect Hum.Mutat. 30 2009 1551 1557
13. N.L. Khan, C. Scherfler, E. Graham, K.P. Bhatia, N. Quinn, A.J. Lees, D.J. Brooks, N.W. Wood, and P. Piccini Dopaminergic dysfunction in unrelated, asymptomatic carriers of a single parkin mutation Neurology 64 2005 134 136
14. N.L. Khan, E.M. Valente, A.R. Bentivoglio, N.W. Wood, A. Albanese, D.J. Brooks, and P. Piccini Clinical and subclinical dopaminergic dysfunction in PARK6-linked parkinsonism: an 18F-dopa PET study Ann. Neurol. 52 2002 849 853
15. H.M. Schipper Heme oxygenase expression in human central nervous system disorders Free Radic. Biol. Med. 37 2004 1995 2011
16. J.E. Clark, R. Foresti, C.J. Green, and R. Motterlini Dynamics of haem oxygenase-1 expression and bilirubin production in cellular protection against oxidative stress Biochem. J. 348 3 2000 615 619
17. P.C. Chen, M.R. Vargas, A.K. Pani, R.J. Smeyne, D.A. Johnson, Y.W. Kan, and J.A. Johnson Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: critical role for the astrocyte Proc. Natl. Acad. Sci. USA 106 2009 2933 2938
18. S.Y. Hung, H.C. Liou, K.H. Kang, R.M. Wu, C.C. Wen, and W.M. Fu Overexpression of heme oxygenase-1 protects dopaminergic neurons against 1-methyl-4-phenylpyridinium-induced neurotoxicity Mol. Pharmacol. 74 2008 1564 1575
19. M.H. Li, Y.N. Cha, and Y.J. Surh Peroxynitrite induces HO-1 expression via PI3K/Akt-dependent activation of NF-E2-related factor 2 in PC12 cells Free Radic. Biol. Med 41 2006 1079 1091
20. A. Samoylenko, E.Y. Dimova, T. Horbach, N. Teplyuk, S. Immenschuh, and T. Kietzmann Opposite expression of the antioxidant heme oxygenase-1 in primary cells and tumor cells: regulation by interaction of USF-2 and Fra-1 Antioxid. Redox Signaling 10 2008 1163 1174
21. E. Barone, F. Di Domenico, R. Sultana, R. Coccia, C. Mancuso, M. Perluigi, and D.A. Butterfield Heme oxygenase-1 posttranslational modifications in the brain of subjects with Alzheimer disease and mild cognitive impairment Free Radic. Biol. Med. 52 2012 2292 2301
22. V. Calabrese, G. Scapagnini, C. Colombrita, A. Ravagna, G. Pennisi, A.M. Giuffrida Stella, F. Galli, and D.A. Butterfield Redox regulation of heat shock protein expression in aging and neurodegenerative disorders associated with oxidative stress: a nutritional approach Amino Acids 25 2003 437 444
23. J. Infante, M. Sierra, P. Sanchez-Juan, I. Garcia-Gorostiaga, I. Gonzalez-Aramburu, C. Fernandez-Viadero, J. Berciano, and O. Combarros Interaction between heme oxygenase-1 genotypes and exposure to pesticides in Parkinson's disease Mov. Disord 26 2011 916 917
24. H.M. Schipper Heme oxygenase-1: role in brain aging and neurodegeneration Exp. Gerontol. 35 2000 821 830
25. H.M. Schipper, W. Song, H. Zukor, J.R. Hascalovici, and D. Zeligman Heme oxygenase-1 and neurodegeneration: expanding frontiers of engagement J. Neurochem. 110 2009 469 485
26. C. Mancuso, and E. Barone The heme oxygenase/biliverdin reductase pathway in drug research and development Curr.Drug Metab 10 2009 579 594
27. J.M. McCord, and M.A. Edeas SOD, oxidative stress and human pathologies: a brief history and a future vision Biomed.Pharmacother. 59 2005 139 142
28. V. Wang, S.Y. Chen, T.C. Chuang, D.E. Shan, B.W. Soong, and M.C. Kao Val-9Ala and Ile+58Thr polymorphism of MnSOD in Parkinson's disease Clin.Biochem. 43 2010 979 982
29. D. Hinerfeld, M.D. Traini, R.P. Weinberger, B. Cochran, S.R. Doctrow, J. Harry, and S. Melov Endogenous mitochondrial oxidative stress: neurodegeneration, proteomic analysis, specific respiratory chain defects, and efficacious antioxidant therapy in superoxide dismutase 2 null mice J. Neurochem. 88 2004 657 667
30. M.J. Lee, I.F. Mata, C.H. Lin, K.Y. Tzen, S.J. Lincoln, R. Bounds, P.J. Lockhart, M.M. Hulihan, M.J. Farrer, and R.M. Wu Genotype-phenotype correlates in Taiwanese patients with early-onset recessive Parkinsonism Mov. Disord 24 2009 104 108
31. A. Prochiantz, U. di Porzio, A. Kato, B. Berger, and J. Glowinski In vitro maturation of mesencephalic dopaminergic neurons from mouse embryos is enhanced in presence of their striatal target cells Proc. Natl. Acad. Sci. USA 76 1979 5387 5391
32. H.R. Xie, L.S. Hu, and G.Y. Li SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease Chin. Med. J. (Engl.) 123 2010 1086 1092
33. P. Sompol, Y. Xu, W. Ittarat, C. Daosukho St, and D. Clair NF-kappaB-associated MnSOD induction protects against beta-amyloid-induced neuronal apoptosis J.Mol. Neurosci. 29 2006 279 288
34. W.L. Chien, T.R. Lee, S.Y. Hung, K.H. Kang, M.J. Lee, and W.M. Fu Impairment of oxidative stress-induced heme oxygenase-1 expression by the defect of Parkinson-related gene of PINK1 J. Neurochem. 117 2011 643 653
35. J. Boada, B. Cutillas, T. Roig, J. Bermudez, and S. Ambrosio MPP(+)-induced mitochondrial dysfunction is potentiated by dopamine Biochem. Biophys. Res. Commun. 268 2000 916 920
36. B.F. van Nuenen, M.M. Weiss, B.R. Bloem, K. Reetz, T. van Eimeren, K. Lohmann, J. Hagenah, P.P. Pramstaller, F. Binkofski, C. Klein, and H.R. Siebner Heterozygous carriers of a Parkin or PINK1 mutation share a common functional endophenotype Neurology 72 2009 1041 1047
37. M. Funayama, Y. Li, T.H. Tsoi, C.W. Lam, T. Ohi, S. Yazawa, E. Uyama, R. Djaldetti, E. Melamed, H. Yoshino, Y. Imamichi, H. Takashima, K. Nishioka, K. Sato, H. Tomiyama, S. Kubo, Y. Mizuno, and N. Hattori Familial Parkinsonism with digenic parkin and PINK1 mutations Mov. Disord 23 2008 1461 1465
38. B. Tang, H. Xiong, P. Sun, Y. Zhang, D. Wang, Z. Hu, Z. Zhu, H. Ma, Q. Pan, J.H. Xia, K. Xia, and Z. Zhang Association of PINK1 and DJ-1 confers digenic inheritance of early-onset Parkinson's disease Hum. Mol. Genet 15 2006 1816 1825
39. I. Mateo, J. Infante, P. Sanchez-Juan, I. Garcia-Gorostiaga, E. Rodriguez-Rodriguez, J.L. Vazquez-Higuera, J. Berciano, and O. Combarros Serum heme oxygenase-1 levels are increased in Parkinson's disease but not in Alzheimer's disease Acta Neurol.Scand. 121 2010 136 138
40. E. Barone, F. Di Domenico, G. Cenini, R. Sultana, C. Cini, P. Preziosi, M. Perluigi, C. Mancuso, and D.A. Butterfield Biliverdin reductase-a protein levels and activity in the brains of subjects with Alzheimer disease and mild cognitive impairment Biochim. Biophys. Acta 1812 2011 480 487
41. F. Di Domenico, E. Barone, C. Mancuso, M. Perluigi, A. Cocciolo, P. Mecocci, D.A. Butterfield, and R. Coccia HO-1/BVR-A system analysis in plasma from probable Alzheimer's disease and mild cognitive impairment subjects: a potential biochemical marker for the prediction of the disease J. Alzheimer's Dis 32 2012 277 289
42. M. Salinas, J. Wang, M. Rosa de Sagarra, D. Martin, A.I. Rojo, J. Martin-Perez, P.R Ortiz de Montellano, and A. Cuadrado Protein kinase Akt/PKB phosphorylates heme oxygenase-1 in vitro and in vivo FEBS Lett. 578 2004 90 94
43. S.L. Montgomery, and W.J. Bowers Tumor necrosis factor-alpha and the roles it plays in homeostatic and degenerative processes within the central nervous system J.Neuroimmune Pharmacol 7 2012 42 59
44. M. Mogi, M. Harada, P. Riederer, H. Narabayashi, K. Fujita, and T. Nagatsu Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients Neurosci.Lett. 165 1994 208 210
45. H.L. Wang, A.H. Chou, T.H. Yeh, A.H. Li, Y.L. Chen, Y.L. Kuo, S.R. Tsai, and S.T. Yu PINK1 mutants associated with recessive Parkinson's disease are defective in inhibiting mitochondrial release of cytochrome c Neurobiol. Dis. 28 2007 216 226
46. H. Murata, M. Sakaguchi, K. Kataoka, and N.H. Huh Multiple functions of PINK1 at different intracellular locations: beyond neurodegenerative diseases Cell Cycle 10 2011 1518 1519
47. M.E. Haque, K.J. Thomas, C. D'Souza, S. Callaghan, T. Kitada, R.S. Slack, P. Fraser, M.R. Cookson, A. Tandon, and D.S. Park Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP Proc. Natl. Acad. Sci. USA 105 2008 1716 1721
48. M.C. Maj, I. Tkachyova, P. Patel, J.B. Addis, N. Mackay, V. Levandovskiy, J. Lee, A.E. Lang, J.M. Cameron, and B.H. Robinson Oxidative stress alters the regulatory control of p66Shc and Akt in PINK1 deficient cells Biochem. Biophys. Res. Commun. 399 2010 331 335
49. Y. Shan, B. Liu, L. Li, N. Chang, H. Wang, D. Wang, H. Feng, C. Cheung, M. Liao, T. Cui, S. Sugita, and Q. Wan Regulation of PINK1 by NR2B-containing NMDA receptors in ischemic neuronal injury J. Neurochem. 111 2009 1149 1160
50. H. Xiong, D. Wang, L. Chen, Y.S. Choo, H. Ma, C. Tang, K. Xia, W. Jiang, Z. Ronai, X. Zhuang, and Z. Zhang Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation J. Clin. Invest. 119 2009 650 660
51. K.J. Kwon, J.N. Kim, M.K. Kim, J. Lee, L.J. Ignarro, H.J. Kim, C.Y. Shin, and S.H. Han Melatonin synergistically increases resveratrol-induced heme oxygenase-1 expression through the inhibition of ubiquitin-dependent proteasome pathway: a possible role in neuroprotection J. Pineal Res. 50 2011 110 123
52. M. Orozco-Ibarra, A.M. Estrada-Sanchez, L. Massieu, and J. Pedraza-Chaverri Heme oxygenase-1 induction prevents neuronal damage triggered during mitochondrial inhibition: role of CO and bilirubin Int. J. Biochem. Cell Biol. 41 2009 1304 1314